Projects per year
Personal profile
Education
- 2007-2012 Ph.D., Graduate Institute of Medical Sciences, Taipei Medical University, Taiwan
- 2006-2007 M.S., School of Medicine, Taipei Medical University
- 2002-2006 B.S., Department of Optometry, Chung Shan Medical University
Experience
- 2017.11- Assistant Professor, Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University
- 2016.03- Assistant Professor, Department of Pharmacology, College of Medicine, Taipei Medical University.
- 2012.01-2015.04 Postdoctoral Research Fellow, School of Nutrition and Health Sciences, Taipei Medical University.
Research Interests
- 藥理
- 毒理
Fingerprint Dive into the research topics where Wan-Jung Lu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Platelet Activation
Medicine & Life Sciences
Blood Platelets
Medicine & Life Sciences
Platelets
Chemical Compounds
Platelet Aggregation
Medicine & Life Sciences
Collagen
Medicine & Life Sciences
p38 Mitogen-Activated Protein Kinases
Medicine & Life Sciences
Phosphorylation
Medicine & Life Sciences
Protein Kinase C
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2016 2019
- 4 Finished
研究多重耐藥蛋白4在第二型糖尿病併發阿斯匹靈阻抗之角色(3/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
研究多重耐藥蛋白4在第二型糖尿病併發阿斯匹靈阻抗之角色(2/3)
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
To Study the Role of Multidrug Resistance Protein 4 on Induction of Aspirin Resistance in Type 2 Diabetes Mellitus
8/1/16 → 7/31/17
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output 2009 2019
- 533 Citations
- 15 h-Index
- 39 Article
New therapeutic strategy of hinokitiol in haemorrhagic shock-induced liver injury
Lu, W-J., Lin, K-H., Tseng, M-F., Yuan, K-C., Huang, H-C., Sheu, J-R. & Chen, R-J., Mar 1 2019, In : Journal of Cellular and Molecular Medicine. 23, 3, p. 1723-1734 12 p.Research output: Contribution to journal › Article
Hemorrhagic Shock
Liver
Wounds and Injuries
Resuscitation
Therapeutics
An Antithrombotic Strategy by Targeting Phospholipase D in Human Platelets
Lu, W. J., Chung, C. L., Chen, R. J., Huang, L. T., Lien, L. M., Chang, C. C., Lin, K. H. & Sheu, J. R., Nov 14 2018, In : Journal of Clinical Medicine. 7, 11Research output: Contribution to journal › Article
Phospholipase D
Blood Platelets
Platelet Activation
Platelet Aggregation
Thrombosis
1
Citation
(Scopus)
Licochalcone A attenuates glioma cell growth in vitro and in vivo through cell cycle arrest
Lu, W. J., Wu, G. J., Chen, R. J., Chang, C. C., Lien, L. M., Chiu, C. C., Tseng, M. F., Huang, L. T. & Lin, K. H., Aug 1 2018, In : Food and Function. 9, 8, p. 4500-4507 8 p.Research output: Contribution to journal › Article
Cell Cycle Checkpoints
Glioma
cell growth
licorice
neoplasms
1
Citation
(Scopus)
Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin αII bβ3 binding in human platelets
Hsia, C. H., Lu, W. J., Lin, K. H., Chou, D. S., Geraldine, P., Jayakuma, T., Chang, N. C. & Sheu, J. R., Apr 1 2018, In : Journal of Cellular and Molecular Medicine. 22, 4, p. 2142-2152 11 p.Research output: Contribution to journal › Article
norcantharidin
Integrins
Fibrinogen
Blood Platelets
Clot Retraction
3
Citations
(Scopus)
A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
Hsia, C. H., Velusamy, M., Sheu, J. R., Khamrang, T., Jayakumar, T., Lu, W. J., Lin, K. H. & Chang, C. C., Dec 1 2017, In : Scientific Reports. 7, 1, 9556.Research output: Contribution to journal › Article
Organometallic Compounds
Ruthenium
Fluorescein-5-isothiocyanate
Platelet Aggregation
Blood Platelets